Microbiotica announces the first close of a £36 million ($48 million) Series C financing.

Recursion announced a $200 million underwritten offering of common stock with leading healthcare and institutional investors.

OMass Therapeutics announced an oversubscribed $310 million (£230 million) Series C financing round.

Chris Molloy on investment in dementia; AI in healthcare; TechBio; BioJapan; bioProcessUK; Green, Conservative and Labour conferences; and BIA Board elections

Poolbeg Pharma announces its unaudited interim results for the six months to 30 June 2026.

£135 million for two life sciences funds, rare disease R&D, Beacon Therapeutics, Basecamp Research’s Series C, Birmingham Life Sciences Week, Liberal Democrat party conference, Women in Biotech Edinburgh